Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension.

Chalmers J, Arima H, Harrap S, Touyz RM, Park JB.

J Hypertens. 2013 May;31(5):1043-8. doi: 10.1097/HJH.0b013e32835f7eef.

PMID:
23429664
2.

[Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].

Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):218-23. doi: 10.1016/j.ancard.2012.05.002. Epub 2012 May 23. French.

PMID:
22695025
3.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
4.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
5.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
6.

Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.

Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.

Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.

7.

Managing hypertension using combination therapy.

Frank J.

Am Fam Physician. 2008 May 1;77(9):1279-86. Review.

8.

Current status of antihypertensive prescription and associated blood pressure control in Japan.

Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.

Hypertens Res. 2006 Mar;29(3):143-51.

PMID:
16755149
9.

50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?

Brown A, Captain B.

Am J Ther. 2011 Nov;18(6):e244-54. doi: 10.1097/MJT.0b013e3181e90863. Review.

PMID:
21436766
10.

Antihypertensive agents for preventing diabetic kidney disease.

Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD004136. doi: 10.1002/14651858.CD004136.pub3. Review.

PMID:
23235603
11.

Pharmacotherapy and blood pressure control in elderly hypertensives in a primary care setting in Bahrain.

Al Khaja KA, Sequeira RP, Damanhori AH.

Aging Clin Exp Res. 2004 Aug;16(4):319-25.

PMID:
15575127
12.

Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.

Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A.

Expert Rev Cardiovasc Ther. 2008 Jun;6(5):759-71. doi: 10.1586/14779072.6.5.759. Review.

PMID:
18510491
13.

Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 2001-2005.

Weiss R, Buckley K, Clifford T.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):706-12.

14.
16.

Current recommendations for the treatment of hypertension: are they still valid?

Moser M.

J Hypertens Suppl. 2002 Feb;20(1):S3-10.

PMID:
11996197
17.

The metabolic syndrome in hypertension: European society of hypertension position statement.

Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G; Scientific Council of the European Society of Hypertension.

J Hypertens. 2008 Oct;26(10):1891-900. doi: 10.1097/HJH.0b013e328302ca38.

PMID:
18806611
18.

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL.

BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008. Review.

19.

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice.

Veronesi M, Cicero AF, Prandin MG, Dormi A, Cosentino E, Strocchi E, Borghi C.

Vasc Health Risk Manag. 2007;3(6):999-1005.

20.

Office management of hypertension in older persons.

Aronow WS.

Am J Med. 2011 Jun;124(6):498-500. doi: 10.1016/j.amjmed.2010.06.029.

PMID:
21605724

Supplemental Content

Support Center